tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Veeva receives another Top 20 Vault CRM commitment, says Raymond James
PremiumThe FlyVeeva receives another Top 20 Vault CRM commitment, says Raymond James
8d ago
Veeva says Gilead commits to Veeva Vault CRM
Premium
The Fly
Veeva says Gilead commits to Veeva Vault CRM
8d ago
Xilio Therapeutics announces initiation of Phase 2 trial for efarindodekin alfa
Premium
The Fly
Xilio Therapeutics announces initiation of Phase 2 trial for efarindodekin alfa
10d ago
Gilead’s Lenacapavir: A Game-Changer in HIV Prevention?
PremiumCompany AnnouncementsGilead’s Lenacapavir: A Game-Changer in HIV Prevention?
11d ago
Gilead Sciences’ Promising Phase 3 Study in Triple Negative Breast Cancer
Premium
Company Announcements
Gilead Sciences’ Promising Phase 3 Study in Triple Negative Breast Cancer
11d ago
Gilead Sciences Launches New Study on GS-5319 for Advanced Solid Tumors
Premium
Company Announcements
Gilead Sciences Launches New Study on GS-5319 for Advanced Solid Tumors
11d ago
Gilead’s Promising Phase 3 Study on Sacituzumab Govitecan for Lung Cancer
PremiumCompany AnnouncementsGilead’s Promising Phase 3 Study on Sacituzumab Govitecan for Lung Cancer
14d ago
Ideaya Biosciences enrolls first patient in IDE397 trial
Premium
The Fly
Ideaya Biosciences enrolls first patient in IDE397 trial
15d ago
Positive Long-Term Outlook for Gilead Sciences’ PrEP Franchise Driven by Descovy’s Performance and Favorable Policy Environment
Premium
Ratings
Positive Long-Term Outlook for Gilead Sciences’ PrEP Franchise Driven by Descovy’s Performance and Favorable Policy Environment
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100